Trevena : Reports Fourth Quarter 2023 Results and Provides C

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update


TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important...

Related Keywords

United States , Carrie Bourdow , Bob Yoder , Trevena Inc , Nasdaq , Company Annual Report On Form , Company Contact , National Institutes Of Health , Epilepsy Therapy Screening Program , Trevena Medical Information Contact Center , Lifesci Advisors , Exchange Commission , Trevena Reports Fourth Quarter , Provides Corporate , Recent Corporate , Supported Epilepsy Therapy Screening Program , Fourth Quarter , Nobel Prize , National Institutes , Investigational New Drug Application , Important Safety Information , Induced Hyperalgesia , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Quarterly Reports , Sci Advisors , Chief Business Officer , Months Ended Dec , Ended Dec , Markets ,